- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07377292
Effectiveness of Core Stabilization Exercises in Rotator Cuff Injuries
May 13, 2026 updated by: Süleyman DALAR, Ahi Evran University Education and Research Hospital
Investigation of the Effectiveness of Core Stabilization Exercises in Patients With Rotator Cuff Tear
The aim of this study is to investigate the effectiveness of core stabilization exercises added to conventional physical therapy in patients aged 40-60 with rotator cuff tears, compared to classic trunk and abdominal muscle strengthening exercises.
Study Overview
Status
Recruiting
Conditions
Detailed Description
Rotator cuff tears are classified as full-thickness and partial tears.
Partial tears are a clinical condition commonly seen in the early stages but can often be treated with conservative methods.
Partial tears can develop as a result of repetitive microtraumas, postural abnormalities, muscle imbalances, and deficiencies in the biomechanical chain.
This condition affects not only the local shoulder muscles but also the scapulothoracic rhythm and trunk control.
Recent studies have shown that shoulder function is closely related not only to local muscle strength but also to the integrity of the kinetic chain.
The trunk (core) muscles are particularly critical for maintaining posture, transferring force during upper extremity movements, and stabilizing the distal segments.
Inadequate trunk stabilization can lead to increased loads on the shoulder joint and elevated stress on the rotator cuff.
Therefore, the aim of this thesis study is to examine the effectiveness of core stabilization exercises applied to individuals diagnosed with rotator cuff partial tears on pain, shoulder function, and clinical recovery, and to contribute scientifically to conservative rehabilitation approaches.
Study Type
Interventional
Enrollment (Estimated)
69
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Süleyman DALAR
- Phone Number: +905384412189
- Email: suleymandalar39@gmail.com
Study Contact Backup
- Name: Başak ÇİĞDEM KARAÇAY
- Phone Number: +905445094803
- Email: basakcigdem@hotmail.com
Study Locations
-
-
-
Kırşehir, Turkey (Türkiye), 40100
- Recruiting
- Kırsehir Ahi Evran University
-
Principal Investigator:
- Süleyman DALAR
-
Sub-Investigator:
- Başak ÇİĞDEM KARAÇAY
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Patients aged 40 to 60 years with a partial supraspinatus tear detected by MRI, reported by a radiologist, and confirmed by a physiatrist.
- Patients who test positive for at least two of the Jobe, Hawkins and Neer tests during the physical examination
- Patients with a visual analog scale (VAS) score between 3.5 and 7.4 millimeters (mm)
Exclusion Criteria:
- Participants do not wish to continue treatment for any reason
- Complete or massive rotator cuff tear
- Use of non-steroidal or steroidal anti-inflammatory drugs
- If they have received shoulder injections or physical therapy within the three months prior to the study
- History of acute trauma
- Presence of neurological disease
- History of surgery on the treated shoulder
- Symptomatic acromioclavicular joint arthritis
- Frozen shoulder
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Core Stabilization Group
Patients received conventional rehabilitation for the affected shoulder 5 days a week for 4 weeks and core stabilization exercises 3 days a week for 4 weeks.
|
The program will be set up as a 35-minute session, including a 5-minute warm-up, three days a week for four weeks, under the supervision of a physical therapist.
Before starting the exercise, the pelvis will be moved forward and backward to teach the lumbar and pelvic neutral positions by contracting and pulling the abdominal muscles to reduce lumbar lordosis.
A neutral position will be established before each session, and care will be taken to maintain the neutral position throughout the exercise.
The exercises consist of three levels and will be applied gradually.
The exercises given at the beginning will be made more difficult individually according to the patients' progress.
When the patient can maintain the exercise position for more than 5 seconds, they will move on to the next level.
A deep breath will be taken before starting the exercise, and the breath will be exhaled during the movement.
The contraction of the transversus abdominis muscle should continue while exhaling.
|
|
Active Comparator: Classic Body Exercise Group
Patients will receive conventional rehabilitation for the affected shoulder 5 days a week for 4 weeks, along with a classic trunk and abdominal strengthening program 3 days a week for 4 weeks.
|
The program will be set up for 3 days a week over 4 weeks, consisting of a 35-minute session including a 5-minute warm-up, supervised by a physical therapist.
Classic Williams 1-2-3 and McKenzie exercises will be provided.
|
|
Placebo Comparator: Control Group
Patients will receive conventional rehabilitation for the affected shoulder five days a week for four weeks.
|
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Visual Analog Scale
Time Frame: Before Treatment (Week 0), at the end of treatment (Week 3) and after treatment (Week 12)
|
Pain intensity on the VAS (visual analog scale) is generally rated as "no pain" 0 points and "the most severe pain imaginable" 10 points (10 cm scale).
Pain intensity scoring ranges are specified as <3 mild pain, 3-6 moderate pain, >6 severe pain.
|
Before Treatment (Week 0), at the end of treatment (Week 3) and after treatment (Week 12)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Tendon Thickness
Time Frame: Before Treatment (Week 0), at the end of treatment (Week 3) and after treatment (Week 12)
|
The supraspinatus tendon will be evaluated using USG.
|
Before Treatment (Week 0), at the end of treatment (Week 3) and after treatment (Week 12)
|
|
Shoulder Pain and Disability Index (SPADI)
Time Frame: Before Treatment (Week 0), at the end of treatment (Week 3) and after treatment (Week 12)
|
The SPADI questionnaire is a measure consisting of a total of 13 questions with two subscales: pain and disability.
The total score and all subscale scores are evaluated on a scale of 0-100.
A high result indicates significant shoulder pain and restricted shoulder movement.
|
Before Treatment (Week 0), at the end of treatment (Week 3) and after treatment (Week 12)
|
|
Range Of Motion (ROM)
Time Frame: Before Treatment (Week 0), at the end of treatment (Week 3) and after treatment (Week 12)
|
Shoulder ROM is measured using a universal goniometer.
Shoulder flexion, extension, abduction, internal rotation, and external rotation ranges are measured in the supine position.
|
Before Treatment (Week 0), at the end of treatment (Week 3) and after treatment (Week 12)
|
|
Core Muscle Strength
Time Frame: Before Treatment (Week 0), at the end of treatment (Week 3) and after treatment (Week 12)
|
Core muscle endurance will be assessed using the McGill core muscle endurance tests, which include the core flexor endurance test, core extensor endurance test, and core right and left side endurance tests.
A stopwatch will be used for measurements, and scores will be recorded in seconds.
Tests will be terminated when the test position deteriorates or when participants indicate they cannot continue the test.
|
Before Treatment (Week 0), at the end of treatment (Week 3) and after treatment (Week 12)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 13, 2026
Primary Completion (Estimated)
December 25, 2026
Study Completion (Estimated)
December 25, 2026
Study Registration Dates
First Submitted
January 22, 2026
First Submitted That Met QC Criteria
January 22, 2026
First Posted (Actual)
January 29, 2026
Study Record Updates
Last Update Posted (Actual)
May 14, 2026
Last Update Submitted That Met QC Criteria
May 13, 2026
Last Verified
May 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- AhievranUERH-FTR-SD-01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.